Quintiles Library

Embrace Value-based Healthcare
Featured White Paper

Value to outcomes (V2O)
Life Science companies that stand to thrive in the increasingly evidence-based marketplace will be those who embrace value-based healthcare and catalyze the system movement toward enhanced outcomes. By understanding the interdependent trends, firms can drive improvements in population health outcomes while navigating these transformational changes....
Show Filters
Case Study
Lung cancer demands more complex treatment regimes than other forms of cancer. It is generally treated by an extensive team of physicians and requires close collaboration to ensure the best treatment for patients. Financial pressures facing the NHS and increasing demands for lung cancer appointments have strained lung cancer services, resulting in capacity issues. This was the challenge facing an NHS University Hospital that had become overloaded and was experiencing escalating waiting times in its lung cancer follow up clinic. It commissioned Quintiles to conduct a pathway mapping and service redesign project to transform its follow up service and utilize the skills of its Cancer Nurse Specialists (CNS). Find out more about how the project created an efficient new pathway and improved...
Read More
Case Study
Patients with metastatic renal cell carcinoma (RCC) are now living longer due to the availability of novel targeted drug therapies. This requires ongoing management of symptoms and side effects for patients living with RCC, including support programs that deliver person-centered services and improve quality of life. However, financial pressures within the NHS have made many clinics struggle with capacity issues and declining levels of middle grade staff.   This was the challenge facing a rural NHS Trust when it commissioned Quintiles to conduct a pathway mapping and service redesign project. The project mapped an innovative new pathway for RCC patients at the Trust. Learn more about this bespoke service and how it has enabled the clinic to handle future demand for its RCC...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 16, 2015 – Quintiles today announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company’s Prime Site program. Hospital Italiano is Quintiles’ first Prime Site in Latin America, complementing the company’s robust network of investigative sites across the globe. A Prime Site is a large clinical institution selected by Quintiles to work together and enhance the institution’s infrastructure for conducting clinical trials in order to accelerate the development of new and more effective medicines. Quintiles and a Prime Site work together to create a more efficient clinical trial process by recruiting, enrolling and retaining more patients through the course of a clinical trial. The new agreement with Hospital Italiano is...
Read More
Fact Sheet
We are committed to delivering quality lab services. Learn more about our CAP ISO15189 accreditation in our global...
Read More
Expert
In this peer-reviewed article Quintiles experts Michelle Leavy and Dan Campion share their insights on designing Quality Improvement registries to help clinicians identify ways to improve treatment processes and patient outcomes. These types of registries have been used in a broad range of condition areas, with diverse designs, data collection methods and funding models. Read full article...
Read More
Media Coverage
Quintiles is widely known as a leading clinical research organization, having been performing clinical trials for pharma and academic sponsors since it was founded in 1982. Recognizing the importance of precision medicine to the future of drug development, Quintiles staked out an early lead in the space through its acquisition of Expression Analysis (EA) in 2013. Nature talked withKellie Yarnell, EA’s VP of Genomic Operations, about the importance of integrating genomics with clinical development. With an academic background in biochemistry and a career focused on genomics and business development, she recently took over as global head of...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 9, 2015 – For the third time in the last four years, Quintiles has been named Best Clinical Research Organization (CRO) at the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress in Washington, D.C., the awards recognize the efforts and achievements of companies and individuals in the vaccine industry during the previous year. “We are honored to once again receive this prestigious award reflecting the insight of many from across the biopharmaceutical industry,” said Phil Breitfeld, vice president and head of the Therapeutic Centers of Excellence at Quintiles. “It is clear to us all that the healthcare industry has a tremendous opportunity to conquer the global burden of disease. We’re proud to be working alongside our...
Read More
Video 01:02
Learn about how our clinical resources and global central labs have helped us develop or commercialize the top 45 oncology drugs of 2013. This is the player to use for single videos on Q.com ...
Fact Sheet
The Quintiles Comprehensive Cancer Panel (QCCP) is a targeted sequencing assay for analysis of genomic variation predictive of response to therapies in clinical...
Read More
Press Release
Combines the complementary strengths and scale of leading biopharmaceutical services and diagnostic information services providers New entity creates superior value proposition through the depth and scale of its capabilities, services and expertise Business to help biopharmaceutical customers bring new drug therapies to market and support precision medicine Joint venture would have generated approximately $575 million in revenues in 2014 Quintiles will own 60% and Quest Diagnostics will own 40% of the joint venture Investor teleconference scheduled for March 31 at 8:30 a.m. ET RESEARCH TRIANGLE PARK, N.C. and MADISON, N.J. – March 31, 2015 – Quintiles and Quest Diagnostics today announced a definitive agreement to form a global clinical trials laboratory services...
Read More
Fact Sheet
Designing the right study to answer the right questions. We help maximize the success of product development efforts by designing and implementing studies that generate the evidence payers are looking for—including real-world...
Read More
Fact Sheet
Quintiles provides a technology solution powered by the Quintiles Infosario® Outcome system to assist registry sponsors in fulfilling the latest QCDR government...
Read More
Expert
In 2012, the Agency for Healthcare Research and Quality (AHRQ) set out to develop the Registry of Patient Registries (RoPR) as a one-stop repository of information about patient registries focused on, but not exclusive to, U.S.-based registries. Michelle Leavy, manager for health policy in the real world late phase research program, is quoted in this BioWorld Today...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 25, 2015 – Quintiles, the world’s largest biopharmaceutical services company, has been named to Forbes magazine’s first-ever “America’s Best Employers” list as rated by more than 20,000 independent survey responses. Quintiles is ranked as the 30th best employer in the United States and comes in third in the “Drugs and Biotechnology” category. In all, 500 companies are included in the 2015 Forbes list. “Being named one of the top employers in the U.S. is a great honor for Quintiles and says a lot about our values, our people and company mission,” said Chief Human Resources Officer Garrett Walker. “Our organization is committed to building and sustaining a work environment that enables our talent to be high performing, successful in achieving their...
Read More
Press Release
SINGAPORE – March 25, 2015 – Quintiles Head of Asia Markets Anand Tharmaratnam, M.D., last night was honored as “Best Life Science Asian Male Executive of the Year” at the BioPharma Asia Industry Awards.  Dr. Tharmaratnam was selected in a vote of biopharmaceutical industry professionals from five distinguished executives shortlisted for the award. “On behalf of the hundreds of voters who made their voices heard in the competition, we are pleased to present this award to Dr. Tharmaratnam,” said Sharon Roessen, Managing Director of Terrapinn Pte Ltd, organizer of BioPharma Asia Convention 2015.  “His visionary leadership and Quintiles’ stellar work were frequent themes in voter comments. We would like to thank Anand for his contributions to advancing Asia’s biopharma industry.” Over the...
Read More
Fact Sheet
オンコロジーの臨床開発:インフォグラフィック...
Read More
Fact Sheet
ワクチンの臨床開発:インフォグラフィック クインタイルズの臨床試験、そのリソースやグローバルなセントラルラボが2013年度の上位35のワクチン製品/化合物の開発・上市に役立ってます。詳細はリンク先をご覧ください。コンテンツは日本語です。
Read More